Bayer Inc. is merging with Takeda Pharmaceutical. Bayer has global offices in Germany and over 300 companies in 74 countries, with a mission of "Science For A Better Life." Takeda was established in 1781 in Japan and has over 38,000 employees and 260,000 shareholders. It is involved in R&D, production, distribution and marketing of drugs. The merger justification includes Takeda and Bayer's past work together and cultural alignment. The estimated cost is $36 million with a breakeven point of $2.2 million in sales annually and a payback period of 5 years. Protection strategies include ownership documents, access restrictions, exit planning, insurance, and an IPO exit
Power point presentation on tariff and import duties converted
Bayer ppt
1. Bayer Inc. Merging with
Takeda Pharmaceutical
Maureen, Mine, Alice, Tim & Tope
2. Over-view of Bayer & Takeda
Bayer has its global office at Leverkusen Germany.
The company comprise of over 302 consolidated companies in over
74 countries globally.
Bayer mission is “Science For A Better Life.”
Its valve is presented by the word LIFE “Leadership, Integrity,
Flexibility and Efficiency.
Takeda was established in June 1781 and incorporated in January
1925, with its headquarters in Japan.
Has over 38,000 employee strength and over 260,784 shareholders
Its business scope comprise R&D, production, distribution,
marketing, export and importation of drugs
3. Over-view Of Germany
Germany is a democratic country with multi-parties. The
countries system of politics is in the constitution.
Germany is the 3rd largest exporter and importer in the world.
France, Netherlands and China are the top 3 trade partners.
Getting license permits and credit may take a long period of time
and getting loans have stiff procedures and these are major
barriers to trading with Germany.
4. Over-View Of South Korea
South Korea is officially known as Republic of Korea. Gained
Independence in 1895.
Has a mixed legal system, and the democratic republic consist of
the executive, legislative and judicial branch
Asia’s fourth largest economy with the largest GDP in the world.
The economy is currently moving towards manufacturing and
services.
The country is a member of OECD, and it was ranked the world’s
eighth largest exporter
South Korea has a basic law concerning foreign investment which
is FIPA (Foreign Investment Promotion Act)
The country focuses on FTA (Free Trade Agreement).
5. Cultural Difference
Germany South Korea
Germans- 91.5%, Turkish 2.4%
and 6.1 % other.
South Korea- Korean English
widely taught in junior high and
high school
Division of labor by gender in
Germany , women are represented
in all walks of life; both sexes
have equal rights
South Korea existence of male
preference, huge gender gap in
education institutions
Homeland of protestant
reformation, mostly protestant
catholic dominated
South Korea , majority opted to
expressing no religious
preference, largely protestant
Christians, Buddhist catholic
and other
6. Bayer Inc. Mode of Entry To Takeda
Merger
Justification for our entry mode
Once worked with Bayer in 1907
South Korea culture model
Takeda business culture
Takeda most valuable assets.
7. Bayer Cost Of Investment
The estimated cost of investment will be $36,000,000 as the
company is worth $35,801,600
Breakeven Point
Total fixed expenses
Contribution margin %
Therefore, using the following information as an annual estimation
Total fixed cost 2,000,000
Sales capacity 7,000,000
Variable expenses 750,000
Contribution margin 89%
Breakeven point= 2,000,000/89%
= $2,247,191.
8. Pay Back Period
year Cash flow ($) Net Invested Cash ($)
0 (36.000,000)
1 10,000,000 (26,000,000)
2 7,000,000 (19,000,000)
3 7,000,000 (12,000,000)
4 7,000,000 (5,000,000)
5 7,000,000
9. Investment Protection Strategy & Exit
Mode
Dedicate time and resources to obtain valid document of
ownership
Restrict access to files and documents to unauthorized individuals
Create a strategic exit strategy for all agreement and investment
Purchase a comprehensive insurance package that covers all
aspects of business
Implement stop loss on all stock in the event of price fall
Exit through Initial Public Offer (IPO)